• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微创与开放食管癌根治术后复发和生存:ENSURE 研究的事后分析。

Recurrence and Survival After Minimally Invasive and Open Esophagectomy for Esophageal Cancer: A Post Hoc Analysis of the Ensure Study.

机构信息

Department of Surgery, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, the Netherlands.

Cancer Center Amsterdam, Department of Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.

出版信息

Ann Surg. 2024 Aug 1;280(2):267-273. doi: 10.1097/SLA.0000000000006280. Epub 2024 Apr 5.

DOI:10.1097/SLA.0000000000006280
PMID:38577796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11224562/
Abstract

OBJECTIVE

To determine the impact of operative approach [open (OE), hybrid minimally invasive (HMIE), and total minimally invasive (TMIE) esophagectomy] on operative and oncologic outcomes for patients treated with curative intent for esophageal and junctional cancer.

BACKGROUND

The optimum oncologic surgical approach to esophageal and junctional cancer is unclear.

METHODS

This secondary analysis of the European multicenter ENSURE study includes patients undergoing curative-intent esophagectomy for cancer between 2009 and 2015 across 20 high-volume centers. Primary endpoints were disease-free survival (DFS) and the incidence and location of disease recurrence. Secondary endpoints included among others R0 resection rate, lymph node yield, and overall survival (OS).

RESULTS

In total, 3199 patients were included. Of these, 55% underwent OE, 17% HMIE, and 29% TMIE. DFS was independently increased post-TMIE [hazard ratio (HR): 0.86 (95% CI: 0.76-0.98), P = 0.022] compared with OE. Multivariable regression demonstrated no difference in absolute locoregional recurrence risk according to the operative approach [HMIE vs OE, odds ratio (OR): 0.79, P = 0.257; TMIE vs OE, OR: 0.84, P = 0.243]. The probability of systemic recurrence was independently increased post-HMIE (OR: 2.07, P = 0.031), but not TMIE (OR: 0.86, P = 0.508). R0 resection rates ( P = 0.005) and nodal yield ( P < 0.001) were independently increased after TMIE, but not HMIE ( P = 0.424; P = 0.512) compared with OE. OS was independently improved following both HMIE (HR: 0.79, P = 0.009) and TMIE (HR: 0.82, P = 0.003) as compared with OE.

CONCLUSION

In this European multicenter study, TMIE was associated with improved surgical quality and DFS, whereas both TMIE and HMIE were associated with improved OS as compared with OE for esophageal cancer.

摘要

目的

确定手术方式(开放手术[OE]、杂交微创[HMIE]和全微创[TMIE]食管癌切除术)对接受根治性治疗的食管和交界性癌症患者的手术和肿瘤学结果的影响。

背景

对于食管和交界性癌症,最佳的肿瘤外科手术方法尚不清楚。

方法

本研究为欧洲多中心 ENSURE 研究的二次分析,纳入了 2009 年至 2015 年间在 20 家大容量中心接受根治性食管癌切除术的癌症患者。主要终点是无病生存率(DFS)和疾病复发的发生率和部位。次要终点包括 R0 切除率、淋巴结产量和总生存率(OS)等。

结果

共纳入 3199 例患者。其中,55%接受 OE,17%接受 HMIE,29%接受 TMIE。与 OE 相比,TMIE 后 DFS 独立增加[风险比(HR):0.86(95%可信区间:0.76-0.98),P = 0.022]。多变量回归显示,根据手术方式,局部区域复发的绝对风险无差异[HMIE 与 OE,比值比(OR):0.79,P = 0.257;TMIE 与 OE,OR:0.84,P = 0.243]。HMIE 后(OR:2.07,P = 0.031),但 TMIE 后(OR:0.86,P = 0.508),系统复发的可能性独立增加。TMIE 后 R0 切除率(P = 0.005)和淋巴结产量(P < 0.001)独立增加,但 HMIE 后则不然(P = 0.424;P = 0.512)与 OE 相比。与 OE 相比,HMIE(HR:0.79,P = 0.009)和 TMIE(HR:0.82,P = 0.003)后 OS 独立改善。

结论

在这项欧洲多中心研究中,与 OE 相比,TMIE 与改善的手术质量和 DFS 相关,而 TMIE 和 HMIE 均与改善的 OS 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06d/11224562/bfb8c9cc1481/sla-280-267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06d/11224562/d011a60a60bc/sla-280-267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06d/11224562/bfb8c9cc1481/sla-280-267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06d/11224562/d011a60a60bc/sla-280-267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06d/11224562/bfb8c9cc1481/sla-280-267-g002.jpg

相似文献

1
Recurrence and Survival After Minimally Invasive and Open Esophagectomy for Esophageal Cancer: A Post Hoc Analysis of the Ensure Study.微创与开放食管癌根治术后复发和生存:ENSURE 研究的事后分析。
Ann Surg. 2024 Aug 1;280(2):267-273. doi: 10.1097/SLA.0000000000006280. Epub 2024 Apr 5.
2
Effect of Phased Implementation of Totally Minimally Invasive Ivor Lewis Esophagectomy for Esophageal Cancer after Previous Adoption of the Hybrid Minimally Invasive Technique: Results from a French Nationwide Population-Based Cohort Study.分期实施全腔镜经左胸入路 Ivor Lewis 食管癌根治术对既往采用杂交微创技术的影响:一项来自法国全国基于人群队列研究的结果。
Ann Surg Oncol. 2022 May;29(5):2791-2801. doi: 10.1245/s10434-021-11110-x. Epub 2021 Nov 26.
3
Lasting symptoms and long-term health-related quality of life after totally minimally invasive, hybrid and open Ivor Lewis esophagectomy.完全微创、杂交和开放 Ivor Lewis 食管切除术治疗后的持续症状和长期健康相关生活质量。
Eur J Surg Oncol. 2022 Mar;48(3):582-588. doi: 10.1016/j.ejso.2021.10.023. Epub 2021 Nov 3.
4
Totally minimally invasive esophagectomy versus hybrid minimally invasive esophagectomy: systematic review and meta-analysis.完全微创食管切除术与杂交微创食管切除术:系统评价与荟萃分析
Dis Esophagus. 2020 Aug 3;33(8). doi: 10.1093/dote/doaa021.
5
Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial.杂交微创食管癌根治术治疗食管癌的 5 年生存结果:MIRO 随机临床试验结果。
JAMA Surg. 2021 Apr 1;156(4):323-332. doi: 10.1001/jamasurg.2020.7081.
6
Effectiveness of Transthoracic Hybrid Minimally Invasive Esophagectomy: A Meta-Analysis.胸腔镜辅助微创食管切除术的有效性:一项荟萃分析。
J Invest Surg. 2021 Sep;34(9):963-973. doi: 10.1080/08941939.2020.1725189. Epub 2020 Feb 9.
7
Could hybrid minimally invasive esophagectomy improve the treatment results of esophageal cancer?杂交微创食管切除术能否改善食管癌的治疗效果?
Eur J Surg Oncol. 2016 Aug;42(8):1196-201. doi: 10.1016/j.ejso.2016.05.027. Epub 2016 Jun 2.
8
Safe Transition from Open to Total Minimally Invasive Esophagectomy for Cancer Utilizing Process Management Methodology.利用流程管理方法实现从开放性食管癌切除术到完全微创食管癌切除术的安全过渡。
J Clin Med. 2024 Jul 26;13(15):4364. doi: 10.3390/jcm13154364.
9
Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial.混合微创与开放食管切除术治疗食管癌患者的健康相关生活质量:多中心、开放标签、随机 III 期对照临床试验分析:MIRO 试验。
Ann Surg. 2020 Jun;271(6):1023-1029. doi: 10.1097/SLA.0000000000003559.
10
The Impact of Hybrid Minimally Invasive Esophagectomy with Neck-Abdominal First Approach on the Short- and Long-Term Outcomes for Esophageal Squamous Cell Carcinoma.颈腹两切口杂交微创手术对食管鳞癌近期和远期疗效的影响。
World J Surg. 2020 Nov;44(11):3829-3836. doi: 10.1007/s00268-020-05655-3.

引用本文的文献

1
The CALLY Index as a Predictive Tool for Postoperative Pneumonia in Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.CALLY指数作为食管鳞状细胞癌术后肺炎的预测工具:一项回顾性队列研究
J Inflamm Res. 2025 Apr 23;18:5463-5475. doi: 10.2147/JIR.S517074. eCollection 2025.
2
Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review).黄酮类化合物在胃肠道癌中的治疗潜力:聚焦信号通路及改善策略(综述)
Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13474. Epub 2025 Feb 28.
3
ASO Author Reflections: Optimizing Lymphadenectomy in Esophageal Cancer: Advances and Considerations.
美国外科医师学会作者反思:优化食管癌淋巴结清扫术:进展与思考
Ann Surg Oncol. 2024 Aug;31(8):5312-5313. doi: 10.1245/s10434-024-15424-4. Epub 2024 May 13.